11 results match your criteria: "OU Health Sciences Center[Affiliation]"
The effective delivery of positive pressure ventilation (PPV) can be challenging during neonatal resuscitation. Achieving a patent airway through an appropriate interface during neonatal resuscitation is critical for avoiding airway obstruction and leakage and optimizing access to PPV. Due to the complexity of face mask ventilation, providers have explored corrective steps.
View Article and Find Full Text PDFJ Vasc Interv Radiol
August 2023
Department of Interventional Radiology, OU Health Sciences Center, University of Oklahoma, Oklahoma City, Oklahoma. Electronic address:
Children (Basel)
June 2022
Pediatrics, University of Oklahoma (OU) College of Medicine, Oklahoma City, OK 73104, USA.
Positive pressure ventilation via a facemask is a critical step in neonatal resuscitation but may be a difficult skill for frontline providers or trainees to master. A laryngeal mask is an alternative to endotracheal intubation for some newborns who require an advanced airway. We present the first case series in the United States in which a laryngeal mask was successfully utilized during resuscitation of newborns greater than or equal to 34 weeks' gestation following an interdisciplinary quality improvement collaborative and focused training program.
View Article and Find Full Text PDFAm J Case Rep
November 2021
Department of Internal Medicine, University of Oklahoma College of Medicine, OU Health Sciences Center, Oklahoma City, OK, USA.
BACKGROUND Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by dysregulated immune system activation and hyperinflammation. Primary HLH is inherited and almost exclusively seen in childhood, while secondary HLH is mainly seen in adults and has a wide variety of triggering factors, including infection, malignancy, autoimmune disease, and immunosuppression. Due to nonspecific presentation, the differential diagnosis for HLH is equally wide.
View Article and Find Full Text PDFCardiovasc Drugs Ther
August 2016
Department of Medicine, Cardiovascular Section, University of Oklahoma HSC and VA Medical Center, OU Health Sciences Center, 920 Stanton L Young Boulevard, Room WP3010, Oklahoma City, OK, 73104, USA.
Guidelines provide recommendations to improve patient outcomes, but many of the recommendations made for treating patients with stable angina are opinion based rather than evidence based. Risk stratification to predict patients at an increased risk of myocardial infarction (MI) and sudden ischemic death, and selection of patients for possible revascularization, is based on expert opinion. Randomized trials have compared optimal medical therapy to revascularization, after the coronary anatomy was known, and yet routine coronary angiography to exclude left main disease is not recommended.
View Article and Find Full Text PDFJ Am Acad Child Adolesc Psychiatry
January 2015
Centers for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities, Atlanta. Electronic address:
J Okla State Med Assoc
February 2010
Department of Medicine, OU Health Sciences Center, Oklahoma City, Norman, OK 73070, USA.
J Okla State Med Assoc
August 2009
Department of Medicine, OU Health Sciences Center, Oklahoma City, OK 73070, USA.
Curr Opin Hematol
September 2003
Department of Medicine, BSEB 302, OU Health Sciences Center, 941 S.L. Young Boulevard, Oklahoma City, OK 73104, USA.
Purpose Of Review: COAT platelets are a recently described subpopulation of cells resulting from simultaneous activation with collagen and thrombin. The complete process by which COAT platelets are produced is still not clear, although significant recent progress has been made.
Recent Findings: COAT platelets retain several procoagulant proteins on their surface by a previously unrecognized mechanism involving transglutaminase mediated conjugation of serotonin to released alpha-granule proteins.
J Okla State Med Assoc
September 1998
OU Health Sciences Center, Department of Medicine, University of Oklahoma College of Medicine, USA.
From September 1982 to August 1997, 767 bone marrow or peripheral blood stem cell transplants have been performed at the Health Sciences Center in Oklahoma. Five hundred and two (502) autologous transplants (AutoTX) preceded by high-dose myeloablative therapy were performed for breast cancer (BC, 36%), non-Hodgkin's lymphomas (NHL, 24%), Hodgkin's disease (HD, 10%), acute myeloid leukemia (AML, 8%), testicular cancer (TC, 4%), multiple myeloma (MM, 2%) and other malignancies (16%). Two hundred and sixty-five (265) allogeneic marrow transplants (AlloTX) (related, unrelated) were carried out in chronic myeloid leukemia (CML, 30%), AML (23%), acute lymphoid leukemia (ALL, 14%), myelodysplastic syndrome (MDS, 9%), severe aplastic anemia (SAA, 8%), and other diseases (14%).
View Article and Find Full Text PDF